Chemokine gene expression in iris-ciliary body during experimental autoimmune uveoretinitis

Current Eye Research

Volumn 24, Issue 6, 2002, Pages 451-457

  Ohta, Kouichi ^a,b   Yamagami, Satoru ^a,c   Wiggert, Barbara ^d   Dana, M Reza ^a   Streilein, J Wayne ^a  

^a SCHEPENS EYE RESEARCH INSTITUTE   (United States)

^b SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c JICHI MEDICAL UNIVERSITY   (Japan)

^d NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Anterior uveal tract; Chemokine; Experimental autoimmune uveoretinitis; Iris ciliary body; Neutrophil

Indexed keywords

EOTAXIN; FREUND ADJUVANT; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INTERPHOTORECEPTOR RETINOID BINDING PROTEIN; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MACROPHAGE INFLAMMATORY PROTEIN 2; RANTES;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTERIOR EYE CHAMBER; AQUEOUS HUMOR; ARTICLE; AUTOIMMUNE DISEASE; CELL TYPE; CILIARY BODY; CONTROLLED STUDY; EYE INFLAMMATION; GENE EXPRESSION PROFILING; IRIS; LEUKOCYTE COUNT; LYMPHOCYTE; MACROPHAGE; MONOCYTE; MOUSE; MOUSE STRAIN; NEUTROPHIL; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; RIBONUCLEASE PROTECTION ASSAY; UVEORETINITIS;

AGING; ANIMALS; AQUEOUS HUMOR; AUTOIMMUNE DISEASES; CHEMOKINES; CILIARY BODY; EYE PROTEINS; GENE EXPRESSION; IRIS; LEUKOCYTE COUNT; MICE; MICE, INBRED STRAINS; RETINITIS; UVEITIS;

EID: 0036965594     PISSN: 02713683     EISSN: None     Source Type: Journal    
DOI: 10.1076/ceyr.24.6.451.8595     Document Type: Article

References (41)

1. Streilein JW. Immune privilege as the result of local tissue barriers and immunosuppressive microenvironments. Curr Opin Immunol. 1993;5:428-432.
2. Rosenbaum JT, McDevitt HO, Guss RB, Egbert PR. Endotoxin-induced uveitis in rats as a model for human disease. Nature. 1980;286:611-613.
3. Caspi RR, Roberge FG, Chan CC, Wiggert B, Chader GJ, Rozenszajn LA, Lando Z, Nussenblatt RB. A new model of autoimmune disease: Experimental autoimmune uveore-tinitis induce in mice with two different retinal antigens. J Immunol. 1988;140:1490-1495.
4. Sano Y, Ksander BR, Streilein JW. Fate of orthotopic corneal allografts in eyes that cannot support ACAID induction. Invest Ophthal Vis Sci. 1995;36:2176-2185.
5. Ohta K, Wiggert B, Taylor AW, Streilein JW. Effects of experimental ocular inflammation on ocular immune privilege. Invest Ophthalmol Vis Sci. 1999;40:2010-2018.
6. Ohta K, Wiggert B, Yamagami S, Taylor AW, Streilein JW. Analysis of immunomodulatory activities of aqueous humor from eyes of mice with experimental autoimmune uveitis. J Immunol. 2000;164:1185-1192.
7. Luster AD. Chemokines: Chemotactic cytokines that mediate inflammation. N Engl J Med. 1998;338:436-445.
8. Butcher EC, Picker LJ. Lymphocyte homing and homeostasis. Science. 1996;272:60-66.
9. Tedla N, Wang HW, McNeil HP, Di Girolamo N, Hampart-zoumian T, Wakefield D, Lloyd A. Regulation of T lymphocyte trafficking into lymph nodes during an im-mune response by the cytokines macrophage inflammatory protein (MIP)-1α and MIP-1β. J Immunol. 1998;161:5663-5672.
10. Kelner GS, Kennedy J, Bacon KB, Kleyensteuber S, Largaespada DA, Jenkins NA, Copeland NG, Bazan JF, Moore KW, Schall TJ. Lymphotoactin: A cytokine that represents a new class of chemokine. Science. 1994;266:1395-1399.
11. Kennedy J, Kelner GS, Kleyensteuber S, Schall TJ, Weiss MC, Yssel H, Schneider PV, Cocks BG, Bacon KB, Zlotnik A. Molecular cloning and functional characterization of human lymphotactin. J Immunol. 1995;155:203-209.
12. Schall TJ, Bacon K, Toy KJ, Goeddel DV. Selective attraction of monocytes and T-lymphocytes of the memory phenotype by cytokine RANTES. Nature. 1990;347:669-671.
13. Schall TJ, Bacon K, Camp RD, Kaspare JW, Goeddel DV. Human macrophage inflammatory protein α (MIP-1α) and MIP-1β chemokines attract distinct populations of lymphocytes. J Exp Med. 1993;177:1821-1826.
14. Ward SG, Bacon K, Westwick J. Chemokines and T lymphocytes: More than an attraction. Immunity. 1998;9:1-11.
15. Helbig H, Kittredge KL, Gurley RC, Thurau SR, Palestine AG, Nussenblatt RB. Endotoxin-induced production of inflammatory mediators by cultures ciliary epithelial cells. Curr Eye Res. 1990;9:501-505.
16. Redmond TM, Wiggert B, Robey FA, Nguyen NY, Lewis MS, Lee L, Chader GJ. Isolation and characterization of monkey interphotoreceptor retinoid-binding protein, an unique extra-cellular matrix component of the retina. Biochemistry. 1985;24:787-793.
17. De Kozak Y, Stainte-Laudy J, Benveniste J, Faure J-P. Evidence for immediate hypersensitivity phenomena in experimental autoimmune uveoretinitis. Eur J Immunol. 1981;11:612-617.
18. Caspi RR, Chan CC, Wiggert B, Chader GJ, Nussenblatt RB. Experimental autoimmune uveoretinitis (EAU) in the mouse model. In: Usui M, Ohno S, Aoki K, eds. Ocular Immunology Today. Amsterdam: Elsevier Science Publishers; 1990:127-130.
19. Yamagami S, Miyazaki D, Ono SJ, Dana MR. Differential chemokine gene expression in corneal transplant rejection. Invest Ophthalmol Vis Sci. 1999;40:2892-2897.
20. Bora NS, Kim MC, Kabeer NH, Simpson SC, Tandhasetti MT, Cirrito TP, Kaplan AD, Kaplan HJ. Experimental autoimmune anterior uveitis. Induction with melanin-associated antigen from the iris and ciliary body. Invest Ophthalmol Vis Sci. 1995;36:1056-1066.
21. Hirose S, Kuwabara T, Nussenblatt RB, Wiggert B, Redmond TM, Gery I. Uveitis induced inprimates by inter-photoreceptor retinoid-binding protein. Arch Ophthalmol. 1986;104:1698-1702.
22. Gery I, Wiggert B, Redmond TM, Kuwabara T, Crawford MA, Vistica BP, Chader GJ. Uveoretinitis and pinealitis induced by immunization with interphotoreceptor retinoid-binding protein. Invest Ophthtal Vis Sci. 1986;27:1296-1300.
23. Crane IJ, Mckillop-Smith S, Wallac CA, Lamont GR, Forrester JV. Expression of the chemokines MIP1α, MCP-1, and RANTES in experimental autoimmune uveitis. Invest Ophthalmol Vis Sci. 2001;42:1547-1552.
24. Chan CC, Caspi RR, Ni M, Leake WC, Wiggert B, Chader GJ, Nussenblatt RB. Pathology of experimental autoimmune uveoretinitis in mice. J Autoimmun. 1990;3:247-255.
25. Inoue H, Takeuchi T, Tanaka T, Usui M, Ando S, Taguchi O. Analysis of the uveitogenic determinant in repeat structure of retinal interphotoreceptor retinoid-binding protein (IRBP). Clin Exp Immunol. 1994;97:219-225.
26. Crowle AJ. Delayed hypersensitivity in the mouse. In: Dixon FJ, Kunkel HG, eds. Advances in Immunology. New York: Academic Press;1975:197-264.
27. Buchanan KL, Murphy JW. Kinetics of cellular infiltration and cytokine production during the efferent phase of a delayed-type hypersensitivity reaction. Immunology. 1997;90:189-197.
28. McColl SR, Staykova MA, Wozniak A, Fordham S, Bruce J, Willenborg DO. Treatment with anti-granulocyte antibodies inhibits the effector phase of experimental autoimmune encephalomyelitis. J Immunol. 1998;161:6421-6426.
29. Larsen CG, Thomsen MK, Gesser B, Thomsen PD, Deleuran BW, Nowak J, Skodt V, Thomsen HK, Deleuran M, Thestrup-Pedersen K. The delayed-type hypersensitivity reaction is dependent on IL-8. J Immunol. 1995;155:2151-2157.
30. Diab A, Abdalla H, Li HL, Shi FD, Zhu J, Hojberg B, Lindquis L, Wretlind B, Bakhiet M, Link H. Neutralization of macrophage inflammatory protein 2 (MIP-2) and MIP-1 alpha attenuates neutrophil recruitment in the central nervous system during experimental bacterial meningitis. Infect Immun. 1999;67:2590-2601.
31. Rajan AJ, Asensio VC, Campbell IL, Brosnan CF. Experimental autoimmune encephalomyelitis on SJL mouse: Effect ofγδ T cells depletion on chemokine and chemokine receptor expression in the central nervous system. J Immunol. 2000;164:2120-2130.
32. Tran EH, Prince EN, Owens T. IFN-γ shapes invasion of the central nervous system via regulation of chemokines. J Immunol. 2000;164:2759-2768.
33. Matejuk A, Vandenbark AA, Burrows GG, Bebo BF Jr., Offner H. Reduced chemokine and chemokine receptor expression in spinal cords of TCR BV8S2 transgenic mice protected against experimental autoimmune encephalomyelitis with BV8S protein. J Immunol. 2000;164:3924-3931.
34. Thelen M, Peveri P, Kernen P, Von Tscharner V, Walz A, Baggiolini M. Mechanism of neutrophil activation by NAP, a novel monocyte-derived peptide agonist. FASEB J. 1988;2:2702-2706.
35. Larsen CG, Anderson AO, Appella E, Oppenheim JJ, Matsushima K. The neutrophil-activating protein (NAP-1) is also chemotactic for T lymphocytes. Science. 1989;243:1464-1466.
36. Baggiolini M, Walz A, Kunkel SL. Neutrophil-activating peptide-1/inteleukin 8, a novel cytokine that activates neutrophils.J Clin Invest. 1989;84:1045-1049.
37. De Boer JH, Hack CE, Verhoeven AJ, Baarsma GS, De Jong PT, Rademakers AJ, De Vries-Knoppert WA, Rothova A, Kikilstra A. Chemoattractant and neutrophil degranulation activities related to interleukin-8 in vitreous fluid and vitreoretinal disorders. Invest Ophthalmol Vis Sci. 1993;34:3376-3385.
38. Verma MJ, Lloyd A, Rager H, Strieter R, Kunkel S, Taub D, Wakefield D. Chemokines in acute anterior uveitis. Curr Eye Res. 1997;16:1202-1208.
39. Whyte A, Binns RM. RANTES and chemokines in rheumatoid arthritis (letter; comment). Lancet. 1994;343:1291-1292.
40. Antony VB, Godbey SW, Kunkel SL, Hott JW, Hartman DL, Burdick MD, Strieter RM. Recruitment of inflammatory cells to pleural space: Chemotactic cytokines, IL-8, and monocyte chemotactic pepetide-1 in human pleural fluids.J Immunol.1993;151:7216-7223.
41. Rosenbaum JT, Raymond WW, Fujikawa LS, Langlois L, Palestine AG, Stamper RL, Freeman WR, Deschenes J, Sell C, Samples JR. Chemotactic activity in aqueous humor from patients with anterior uveitis. Clin Immunol Immunopathol. 1987;42:265-273.